The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions.
Open accessAbstract
We examined the role of cytokines in the cutaneous response to the application of trinitrochlorobenzene (TNCB) in both nonsensitized and sensitized mice, i.e., in the irritant reaction (IR) and contact hypersensitivity reactions (CH). When administered immediately before challenge, anti-tumor necrosis factor (TNF) antibody abrogated the ear swelling response in CH; antibody directed against interferon gamma or antibodies to both granulocyte/macrophage colony-stimulating factor and interleukin 3 (IL-3) had a partial inhibitory effect; anti-IL-2 receptor antibody had no effect. Anti-TNF prevented the various features of the CH, as seen on histological sections, e.g., leukocyte infiltration and hemorrhages within the dermis and keratinocytes necrosis. Anti-TNF antibody also prevented the IR. The presence of TNF mRNA was evaluated on Northern blots; TNF-alpha mRNA was detectable in an untreated ear, increased after the application of TNCB in nonsensitized mice, and was highest in sensitized mice. TNF mRNA accumulation, which was evident 0.5 h after hapten application and lasted greater than 72 h, was abolished by treatment with anti-TNF antibody, thus suggesting an auto-amplification of TNF production. The cellular origin of TNF mRNA was explored by in situ hybridization; basal keratinocytes showed the highest labeling, but TNF mRNA was also detectable in cells of the dermal infiltrate. After hapten (TNCB) application at sites susceptible (the ear) or resistant (the foot pad) to CH or IR, a close correlation was observed between TNF mRNA accumulation and the intensity of the inflammatory reaction. The major role played by TNF in both the CH and the IR explains the histologically similar aspects of these reactions and the extreme variability of these reactions at various anatomical sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.625 · Cited by 1,697
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Self-citationCher, D. J., & Mosmann, T. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3688 · Cited by 957
Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral Malaria
Grau, G. E., Fajardo, L. F., Piguet, P.-F., Allet, B., Lambert, P.-H., & Vassalli, P. (1987) · Science · doi:10.1126/science.3306918 · Cited by 736
Self-citationPober, J. S. (1988) · PubMed · Cited by 594
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Self-citationRequirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A.-P., & Vassalli, P. (1990) · Nature · doi:10.1038/344245a0 · Cited by 454
Self-citationSpitalny, G. L., & Havell, E. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.5.1560 · Cited by 367
Grau, G. E., Heremans, H., Piguet, P. F., Pointaire, P., Lambert, P. H., Billiau, A., & Vassalli, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5572 · Cited by 318
Self-citationGocinski, B. L., & Tigelaar, R. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4121 · Cited by 314
The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
Fong, T. A. T., & Mosmann, T. R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.2887 · Cited by 302
Sappino, A. P., Huarte, J., Belin, D., & Vassalli, J. D. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.5.2471 · Cited by 279
Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.
Fong, T. A., & Mosmann, T. R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1744 · Cited by 234
Lowenthal, J. W., Corthésy, P., Tougne, C., Lees, R., MacDonald, H. R., & Nabholz, M. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3988 · Cited by 197
Eisen, H. N., Orris, L., & Belman, S. (1952) · The Journal of Experimental Medicine · doi:10.1084/jem.95.5.473 · Cited by 185
Griffiths, C. E. M., & Nickoloff, B. J. (1989) · PubMed · Cited by 147
Piguet, P. F., Grau, G. E., & VASSALLI, P. (1990) · Europe PMC (PubMed Central) · Cited by 147
Self-citationUnequivocal Delayed Hypersensitivity in Mast Cell-Deficient and Beige Mice
Galli, S. J., & Hammel, I. (1984) · Science · doi:10.1126/science.6494907 · Cited by 121
Tumor necrosis factor expression in human epithelial tumor cell lines.
Spriggs, D. R., Imamura, K., Rodriguez, C., Sariban, E., & Kufe, D. W. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113341 · Cited by 101
Medenica, M. M., & Rostenberg, A. (1971) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12260992 · Cited by 82
Collart, M. A., Belin, D., Vassalli, J. D., & VASSALLI, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.3.949 · Cited by 75
Self-citationCELLULAR AND VASCULAR COMPONENTS OF ALLERGIC CONTACT DERMATITIS.
Flax, M. H., & Caulfield, J. (1963) · PubMed · Cited by 63
Bigby, M. E., KWAN, T. H., & Y, M. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12460983 · Cited by 47
The cellular infiltrate in contact hypersensitivity to picryl chloride in the mouse
Roupe, G., & Ridell, B. (1979) · Acta Dermato Venereologica · doi:10.2340/0001555559191195 · Cited by 40
Taverne, J., Rayner, D. C., van der Meide, P. H., et al. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171229 · Cited by 39
Olsen, W. M., & Elgjo, K. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12873961 · Cited by 35
Cited by
Schweiger, D., Baufeld, C., Drescher, P., Oltrogge, B., Höpfner, S., Mess, A., Lüttke, J., Rippke, F., Filbry, A., & Max, H. (2013) · Skin Pharmacology and Physiology · doi:10.1159/000348473 · Cited by 1,346
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
Woolf, C. J., Allchorne, A., Safieh‐Garabedian, B., & Poole, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701148 · Cited by 675
Early molecular events in the induction phase of contact sensitivity.
Enk, A. H., & Katz, S. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1398 · Cited by 650
Metadata
- Authors
- Piguet, P. F., Grau, G. E., Hauser, C., & Vassalli, P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-03-01
- Volume
- 173
- Issue
- 3
- Pages
- 673-679
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2148726934
- Cited by
- 340
- References
- 27
- FWCI
- 35.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.